[HTML][HTML] Oral microbiota in the oral-genitourinary axis: identifying periodontitis as a potential risk of genitourinary cancers
S Yuan, C Fang, WD Leng, L Wu, BH Li… - Military Medical …, 2021 - Springer
Periodontitis has been proposed as a novel risk factor of genitourinary cancers: although
periodontitis and genitourinary cancers are two totally distinct types of disorders …
periodontitis and genitourinary cancers are two totally distinct types of disorders …
New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials
P He, Q Dai, X Wu - Environmental Research, 2023 - Elsevier
A high number of cancer-related deaths (up to 90) are due to metastasis and simple
definition of metastasis is new colony formation of tumor cells in a secondary site. In tumor …
definition of metastasis is new colony formation of tumor cells in a secondary site. In tumor …
[HTML][HTML] Characterisation of cell lines derived from prostate cancer patients with localised disease
L Moya, C Walpole, F Rae, S Srinivasan… - Prostate Cancer and …, 2023 - nature.com
Background Prostate cancer is a broad-spectrum disease, spanning from indolent to a
highly aggressive lethal malignancy. Prostate cancer cell lines are essential tools to …
highly aggressive lethal malignancy. Prostate cancer cell lines are essential tools to …
Clinicopathological significance of unraveling mitochondrial pathway alterations in non‐small‐cell lung cancer
KL Hertweck, KS Vikramdeo, JN Galeas… - The FASEB …, 2023 - Wiley Online Library
Early detection, accurate monitoring, and therapeutics are major problems in non‐small‐cell
lung cancer (NSCLC) patients. We identified genomic copy number variation of a unique …
lung cancer (NSCLC) patients. We identified genomic copy number variation of a unique …
[HTML][HTML] MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer
MYB acts as a potentiator of aggressiveness and castration resistance in prostate cancer
(PCa) through aberrant activation of androgen receptor (AR) signaling. Since Black men …
(PCa) through aberrant activation of androgen receptor (AR) signaling. Since Black men …
[HTML][HTML] Antitumor activity of alkylphospholipid edelfosine in prostate cancer models and endoplasmic reticulum targeting
ELH Dakir, C Gajate, F Mollinedo - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Prostate cancer is the second most frequent cancer and the fifth leading cause of cancer
death among men worldwide. While the five-year survival in local and regional prostate …
death among men worldwide. While the five-year survival in local and regional prostate …
MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer
Background Aberrant activation of androgen receptor signalling following castration therapy
is a common clinical observation in prostate cancer (PCa). Earlier, we demonstrated the role …
is a common clinical observation in prostate cancer (PCa). Earlier, we demonstrated the role …
[HTML][HTML] Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils
DL Costanzo-Garvey, AJ Case, GF Watson… - Clinical & Experimental …, 2022 - Springer
Bone metastatic prostate cancer (BM-PCa) remains one of the most difficult cancers to treat
due to the complex interactions of cancer and stromal cells. We previously showed that bone …
due to the complex interactions of cancer and stromal cells. We previously showed that bone …
[HTML][HTML] Histone variant H2A. J is enriched in luminal epithelial gland cells
CE Redon, Z Schmal, G Tewary, A Mangelinck… - Genes, 2021 - mdpi.com
H2A. J is a poorly studied mammalian-specific variant of histone H2A. We used
immunohistochemistry to study its localization in various human and mouse tissues. H2A. J …
immunohistochemistry to study its localization in various human and mouse tissues. H2A. J …
[HTML][HTML] An In Vitro Evaluation and Network Pharmacology Analysis of Prospective Anti-Prostate Cancer Activity from Perilla frutescens
PJB Garcia, SKH Huang, KA De Castro-Cruz, RB Leron… - Plants, 2023 - mdpi.com
Perilla frutescens (L.) Britt. is extensively cultivated in East Asia as a dietary vegetable, and
nutraceuticals are reportedly rich in bioactive compounds, especially with anticancer …
nutraceuticals are reportedly rich in bioactive compounds, especially with anticancer …